We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – Products

A strand of mRNA.
Product News

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) has announced the grand opening of its new cGMP mRNA manufacturing facility.
Cells.
Product News

Thermo Fisher Scientific Introduces Animal Origin-Free Formulation To Support Scaling of Cell Therapy Manufacturing

Breakthrough medium delivers speed and scale to CAR-T cell therapy manufacturers.
Double helix structure of DNA.
Product News

University of Liverpool To Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical

The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.
Antibodies.
Product News

Therapeutic Potential of CD20 X CD3 Bispecific Antibodies

As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Cancer immunotherapy cells
Compendium

Cancer Immunotherapies: The Paths From Models to Treatments

In this compendium, Technology Networks presents a collection of handpicked resources, including infographics, listicles, an article and webinar, that will help you to learn more about the latest advancements with disease modeling and cancer immunotherapies.
Cell Therapy
Whitepaper

Advances in Cell Therapy

This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
A healthcare worker tends to a patient receiving treatment in the hospital
Whitepaper

Improving Cancer Patient Care With Professor Mark Lawler

In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.
mRNA.
Product News

Lonza and Oxford Nanopore To Collaborate on Novel Test To Accelerate Analysis of mRNA Products

Collaboration aims to commercialize a Current Good Manufacturing Practice (cGMP) validated test to enable advanced and innovative analysis for multiple critical quality attributes of mRNA products.
Novel CAR Technology To Transform Cancer Therapy
Whitepaper

Novel CAR Technology To Transform Cancer Therapy

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.
GMP & RUO Grade iPSC Gene Editing & Differentiation Services
Product
Advertisement

GMP & RUO Grade iPSC Gene Editing & Differentiation Services

Complete iPSC/MSC manufacturing platform: Generate, CRISPR engineer, and differentiate iPSCs into NK cells, T cells, neurons, or cardiomyocytes at Applied StemCell’s new GMP manufacturing facility in Milpitas, California.
Advertisement